U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07724561) titled 'Suvarnaprashana Pilot Study in Healthy Nepali Children Aged 2-5 Years' on July 07.
Brief Summary: Introduction This prospective, single-site, non-randomized, open-label controlled pilot study aims to generate preliminary evidence on the short-term safety and potential immunomodulatory effects of Suvarnaprashana (SP), a traditional Ayurvedic intervention involving daily oral administration of a gold-based formulation (Suvarna Bhasma triturated with honey and ghee).
Study Objectives Primary objectives focus on safety (monitoring adverse events, serious adverse events, and biochemical markers) and exploratory immunological changes (wh...